quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:25:20·37d
INSIDERFiling
Stoke Therapeutics Inc. logo

CHIEF MEDICAL OFFICER Ticho Barry converted options into 33,850 shares, increasing direct ownership by 171% to 53,648 units (SEC Form 4)

STOK· Stoke Therapeutics Inc.
Health Care
Original source

Companies

  • STOK
    Stoke Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Feb 24UpdateWolfe Research$40.00
  • Feb 5UpdateGuggenheim$60.00
  • Jan 5UpdateChardan Capital Markets$35.00
  • Jul 18UpdateJefferies$30.00
  • Dec 20UpdateChardan Capital Markets$24.00
  • Oct 14UpdateLeerink Partners$18.00

Related

  • SEC1d
    SEC Form DEFA14A filed by Stoke Therapeutics Inc.
  • SEC1d
    SEC Form DEF 14A filed by Stoke Therapeutics Inc.
  • PR7d
    Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
  • PR15d
    Stoke Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference
  • PR15d
    The Credibility Filter Wall Street Uses to Sort Biotech Winners
  • INSIDER16d
    SEC Form 4 filed by Kahn Clare
  • INSIDER16d
    SEC Form 3 filed by new insider Kahn Clare
  • SEC16d
    SEC Form 8-K filed by Stoke Therapeutics Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022